1Davies H, Bignell GR. and Cox C (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954.

2Dhomen N, Da Rocha Dias S. and Hayward R (2010) Inducible expression of V600E BRAF using tyrosinase-driven Cre recombinase results in embryonic lethality. Pigment Cell Melanoma Research 23:112-120.

3Christine L and Lionel L (2012) BRAF : biologie et fonction. Correspondances enOnco-Théranostic.

4Wang YL, Dai X, Li YD, Cheng RX, Deng B, et al. (2015) Study of PIK3CA, BRAF, and KRAS mutations in breast carcinomas among Chinese women in Qinghai. Genetics and molecular research: GMR.7p.

5Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series. 44:211.

6Librado P and Rozas J (2009) DnaSP v5: Software for Comprehensive Analysis of DNA Polymorphic Data. Bioinformatics 25:1451-1452.

7Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2013) MEGA6: Molecular Evolutionary Genetics Analysis Version 6.0. The Society for Molecular Biology and Evolution, Oxford University, Oxford.

8Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595.

9Fu YX and Li WH (1993) Statistical tests of neutrality of mutations. Pub Med 133:693-709.

10Fay JC and Wu CI (2000) Hitchhiking under positive Darwinian selection. Genetics 155:1405– 1413.

11Ramos-Onsins SE and Rozas J (2002) Statistical properties of new neutrality tests against population growth. Molecular Biology and Evolution19: 2092-2100.

12Excoffier L and Lischer HEL (2010) Arlequin suite, Ver 3.5: A new series of programs to perform population genetics analyses under Linux and Windows. Molecular Ecologie Resources 10: 564- 567.

13Robinson MJ and Cobb MH (1997) Mitogen-activated protein kinase pathways. Current Opinion in Cell Biology 9:180- 186.

14Spring KJ, Zhao ZZ, Karamatic R, et al. (2006) High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131:1400-1407.

15RajagopalanH, Bardelli A ,Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE (2002) Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418: 934.

16Kimura ET, Nikiforova MN, Zhu Z (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457.

17Eccles SA (2000) Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signaling. Recent Results Cancer Research 157:41-54.

18Benfodda M, Marinho E, Kuma R, Beaudoux O, Lamoril J, Deschamps L, et al. (2016) MELADIAG : un panel de biomarqueurs d'ADN dédié au diagnostique du mélanome.

19Hanahan D and Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-74.

20Lekka M, Laidler P, Gil D, Lekki J, Stachura Z, et al. (1999) The elasticity of normal and cancerous human bladder cells studied by scanning force microscopy. European Biophysics Journal 28:312-316.

21Guck J, Schinkinger S, Lincoln B, Wottawah F, Ebert S, Romeyke M, Lenz D, et al. (2005) Optical Deformability as an Inherent Cell Marker for Testing Malignant Transformation and Metastatic Competence. Biophysical Journal 88: 3689-3698.